Related Experiment Video
Updated: Apr 5, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Maternal fatty acid levels during pregnancy, childhood lung function and atopic diseases. The Generation R Study
E Rucci1,2,3, H T den Dekker1,2,3, J C de Jongste2
1The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Insights
Maternal polyunsaturated fatty acid (PUFA) levels during pregnancy may impact childhood atopic disease risk. Higher maternal total PUFA and n-6 PUFA were linked to decreased asthma but increased eczema risk in children.
Area of Science:
- Perinatal nutrition
- Immunology
- Epidemiology
Background:
- Maternal diet during pregnancy is crucial for fetal development.
- Fatty acid profiles may influence fetal immune system maturation.
- This may affect the risk of developing atopic diseases in childhood.
Purpose of the Study:
- To investigate the association between maternal fatty acid levels during pregnancy and respiratory health in school-aged children.
- To examine the relationship between maternal fatty acids and the prevalence of asthma and eczema in children.
- To explore potential links between maternal lipid status and childhood airway inflammation.
Main Methods:
- Prospective cohort study of 4976 subjects.
- Maternal plasma glycerophospholipid fatty acids measured via gas chromatography in the second trimester.
- Childhood asthma, eczema, airway resistance (Rint), and fractional exhaled nitric oxide (FeNO) assessed at age 6.
Main Results:
- No consistent associations found between maternal total PUFA, n-6 PUFA, n-3 PUFA, or n-6/n-3 ratio and child's Rint or FeNO.
- Higher maternal total PUFA and total n-6 PUFA levels were associated with reduced asthma risk (OR 0.76-0.71) but increased eczema risk (OR 1.16-1.21).
- Associations were partly explained by maternal linoleic acid (LA) levels; not explained by child's PUFA intake.
Conclusions:
- Elevated maternal total PUFA and n-6 PUFA levels during pregnancy appear to modify childhood atopic disease risk.
- Specific mechanisms underlying these associations require further investigation.
- Findings highlight the potential role of maternal fatty acid status in pediatric allergy development.
Background:
Maternal fatty acid status during pregnancy might influence foetal immunological development and subsequently the risk of childhood atopic diseases.
Objective:
To examine the associations of maternal fatty acid levels during pregnancy with airway resistance and inflammation, asthma and eczema, in school-age children.
Methods:
This study among 4976 subjects was embedded in a population-based prospective cohort study. We measured maternal plasma glycerophospholipid fatty acid levels by gas chromatography during the second trimester of pregnancy (mean gestational age: 20.7 (± 1.1) weeks). At the age of 6 years, airway resistance and inflammation were measured by interrupter technique (Rint) and fractional exhaled nitric oxide (FeNO), and current physician-diagnosed asthma and eczema were assessed by ISAAC-based questionnaires. Multiple linear and logistic regression models were adjusted for socio-demographic, lifestyle and anthropometric factors.
Results:
We did not observe consistent associations of maternal total polyunsaturated fatty acid (PUFA), total n-6 PUFA, total n-3 PUFA levels and n-6/n-3 PUFA ratio during pregnancy with child's Rint and FeNO. Higher maternal total PUFA and total n-6 PUFA levels were associated with a decreased risk of childhood asthma (odds ratios (95% confidence interval): 0.76 (0.60, 0.97) and 0.71 (0.52, 0.96) per standard deviation score (SDS) increase of total PUFA and total n-6 PUFA levels, respectively) and with an increased risk of childhood eczema (1.16 (1.05, 1.28) and 1.21 (1.07, 1.37)). The observed associations were partly explained by Linoleic acid (LA, C18:2n-6) levels. Maternal total n-3 PUFA levels and n-6/n-3 PUFA ratio were not associated with current asthma and eczema. The observed associations were not explained by child's PUFA intake.
Conclusions And Clinical Relevance:
Higher maternal total PUFA and total n-6 PUFA levels during pregnancy seem to influence the risk of atopic diseases in childhood. The underlying mechanisms need to be further explored.
More Related Videos
11:08The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
Published on: March 13, 2014
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Related Concept Videos
Development of the Oral Microbiota
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Asthma-I: Introduction
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Development of Human Microbiota